Abnormal proteolysis in sick newborns

Area of Science:

• Neonatal Medicine
• Hematology
• Pediatrics

Background:

• Neonatal hemostasis is complex and differs significantly from adult hemostasis.
• Infants are prone to bleeding and thrombotic disorders due to immature coagulation and fibrinolytic systems.

Purpose of the Study:

• To investigate defects in the coagulation and fibrinolytic systems in newborn infants on their first day of life.
• To determine if specific patterns of hemostatic abnormalities are associated with Idiopathic Respiratory Distress Syndrome (IRDS) or mixed neonatal disorders.
• To explore the relationship between illness severity, clinical course, and the presence of multiple hemostatic defects.

Main Methods:

• Studied 87 newborn infants within the first 24 hours of life.
• Assessed coagulation and fibrinolytic system parameters, including Factor V, fibrinogen, and fibrin/fibrinogen degradation products (FDP).
• Categorized infants into groups based on diagnosis (IRDS vs. mixed neonatal disorders) and clinical outcomes (survival vs. death).

Main Results:

• Factor V, fibrinogen, and FDP abnormalities were most frequent among the studied parameters.
• The presence of "multiple defects" in hemostasis was significantly associated with illness severity and mortality (85% of deceased infants had multiple defects vs. 28% of survivors).
• No significant difference in the pattern of hemostatic abnormalities was observed between infants with IRDS and those with mixed neonatal disorders.

Conclusions:

• Neonatal hemostatic defects are common and can be severe, particularly in critically ill infants.
• Multiple hemostatic defects are linked to poor prognosis in newborns.
• Potential mechanisms for these defects include impaired synthesis (e.g., vitamin K deficiency, liver damage) and abnormal proteolytic activity leading to dysregulated coagulation and/or fibrinolysis.